Neuropsychopharmacology (N) is a scholarly journal dedicated to publishing research in the field of Pharmacology, Toxicology and Pharmaceutics. Nature Publishing is the publisher of this esteemed journal. The P-ISSN assigned to Neuropsychopharmacology is 0893-133X and its abbreviated form is Neuropsychopharmacology.
Neuropsychopharmacology is an international scientific journal and the official publication of the American College of Neuropsychopharmacology (ACNP). This journal focuses on clinical and basic science contributions that advance our understanding of the brain and behaviour, especially as related to the molecular, cellular, physiological and psychological properties of agents acting within the central nervous system and the identification of the new molecular targets for the development of the next generation of drugs. While original reports are preferred, mini-reviews and perspectives are invited by the editorial office.
Journal title | Neuropsychopharmacology (N) |
Abbreviation | Neuropsychopharmacology |
Print ISSN | 0893-133X |
Online ISSN | 1470-634X |
Publisher Name | Nature Publishing |
Editor-in-chief | Tony P George, University of Toronto, Toronto, ON, Canada |
Subject Category | Pharmacology, Toxicology and Pharmaceutics |
Abbreviation : ISO Journal abbreviation refers to the shortened form or acronym used to represent the full title of a scholarly journal. The ISO4 Abbreviation of Neuropsychopharmacology Journal is Neuropsychopharmacology.
The Ranking of the Journal in 2024 is 975. Ranking systems aim to provide an indication of a journal's quality, influence, and prestige within a specific field or discipline.
The Journal's Impact Factor in 2024 is 7.9. it is all calculated by Clarivate, which means how many times a particular citation has been published in the past two years.
The Journal SCImago in 2024 is 2.385. It is measured by the number of citations which are made by the particular journals, and the journal from where the citations arrived from.
The Journal's H-Index in 2024 is 238. The H-index is calculated on how many times a particular author is cited and the number of published papers that a particular author has.
The Journal's Quartile is Q1. A quartile has three points, which are the upper quartile, median, and lower quartile. The main motive of the quartile is to calculate the interquartile range, that resembles the changes across the median.
The Journal is indexed in (Indexing details)
PubMed | Scopus | Web of Science | UGC | Embase | DOAJ |
---|---|---|---|---|---|
❌ | ✅ | ✅ | ✅ | ❌ | ❌ |
Indexing services aim to make it easier for researchers, scholars, and readers to discover and access articles from various journals within a specific field or discipline.
Abbreviation | Neuropsychopharmacology |
Impact Factor | 7.9 |
SJR | 2.385 |
SNIP | 1.864 |
Ranking | 975 |
CiteScore | 14.0 |
H-Index | 238 |
The Editor-in-chief of the Journal is Tony P George, University of Toronto, Toronto, ON, Canada
Processing/Submission Fee : Article submission/Processing fees (APC), also known as manuscript Publication fees or processing fees (APC), are charged by journals to authors for submitting/publishing their research papers/article.
The APC/Submission (Publication) Fee of the Journal is $4790, £3190, €3690
Call for paper : The Journal invites original research contributions for consideration of publication in Neuropsychopharmacology journal.
Journal seeking submissions in the broad areas of Pharmacology, Toxicology and Pharmaceutics that align with journal's focus on Pharmacology, Toxicology and Pharmaceutics.
for details about call for paper please visit to the official website of the journal to check the details about call for papers.
Publishing in Neuropsychopharmacology involves the following steps:
No, the journal is not indexed in PubMed.
Yes, the journal is indexed in Scopus.
Yes, the journal is indexed in UGC.
No, the journal is not indexed in Index copernicus.
No, journal is not a predatory journal.
The Impact Factor of the Journal is 7.9.
The Ranking of the Journal is 975.
Yes the journal is a peer-reviewed journal.
Yes the journal is a peer-reviewed journal and good to publish your paper.
Neuropsychopharmacology (N) is a scholarly journal dedicated to publishing research in the field of Pharmacology, Toxicology and Pharmaceutics. Nature Publishing is the publisher of this esteemed journal.
No, Neuropsychopharmacology is not a open access journal.